Tech Company Financing Transactions
Mederi Therapeutics Funding Round
On 12/24/2013, Mederi Therapeutics raised $18.5 million in funding from Acadia Woods Ventures, Horizon Technology Finance and private investors.
Transaction Overview
Company Name
Announced On
12/24/2013
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$18,500,000
Round
Undisclosed
Proceeds Purpose
The funds will be used to support and expand on the rapidly growing use of Mederi's Stretta therapy for Gastroesophageal Reflux Disease (GERD) and Secca therapy for Bowel Incontinence.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8 Sound Shore Dr. 304
Greenwich, CT 06830
USA
Greenwich, CT 06830
USA
Phone
Website
Email Address
Overview
Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease. Mederi Therapeutics holds over 80 patents in the use of RF energy for treatment of disease states affecting the human digestive system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Dennis
Browse more venture capital transactions:
Prev: 12/24/2013: BotanoCap venture capital transaction
Next: 12/24/2013: NextBit Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs